Brightness-Equalized Quantum Dots Improve Biological Imaging
News Oct 05, 2015
“In this work, we have made two major advances—the ability to precisely control the brightness of light-emitting particles called quantum dots, and the ability to make multiple colors equal in brightness,” explained Andrew M. Smith, an assistant professor of bioengineering at Illinois. “Previously light emission had an unknown correspondence with molecule number. Now it can be precisely tuned and calibrated to accurately count specific molecules. This will be particularly useful for understanding complex processes in neurons and cancer cells to help us unravel disease mechanisms, and for characterizing cells from diseased tissue of patients.”
“Fluorescent dyes have been used to label molecules in cells and tissues for nearly a century, and have molded our understanding of cellular structures and protein function. But it has always been challenging to extract quantitative information because the amount of light emitted from a single dye is unstable and often unpredictable. Also the brightness varies drastically between different colors, which complicates the use of multiple dye colors at the same time. These attributes obscure correlations between measured light intensity and concentrations of molecules,” stated Sung Jun Lim, a postdoctoral fellow and first author of the paper, “Brightness-Equalized Quantum Dots".
According to the researchers, these new materials will be especially important for imaging in complex tissues and living organisms where there is a major need for quantitative imaging tools, and can provide a consistent and tunable number of photons per tagged biomolecule. They are also expected to be used for precise color matching in light-emitting devices and displays, and for photon-on-demand encryption applications. The same principles should be applicable across a wide range of semiconducting materials.
“The capacity to independently tune the QD fluorescence brightness and color has never before been possible, and these BE-QDs now provide this capability,” said Lim. “We have developed new materials-engineering principles that we anticipate will provide a diverse range of new optical capabilities, allow quantitative multicolor imaging in biological tissue, and improve color tuning in light-emitting devices. In addition, BE-QDs maintain their equal brightness over time while whereas conventional QDs with mismatched brightness become further mismatched over time. These attributes should lead to new LEDs and display devices not only with precisely matched colors—better color accuracy and brightness—but also with improved performance lifetime and improved ease of manufacturing.” QDs are already in use in display devices (e.g. Amazon Kindle and a new (Samsung TV).ease of manufacturing.” QDs are already in use in display devices (e.g. Amazon Kindle and a new Samsung TV).ease of manufacturing.” QDs are already in use in display devices (e.g. Amazon Kindle and a new Samsung TV).
Researchers have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease -- Duchenne muscular dystrophy (DMD) -- for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.READ MORE
Researchers have clarified, for the first time, the mechanism behind a very rare brain disorder called MICPCH syndrome in animal models. Information gleaned from this study could also inform research into other, more common neurological disorders such as intellectual disability, epilepsy, and autism.